2 completed, 2 unknown. 4 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Unknown 2 |
| Phase 2 | 4 | Completed 2, Unknown 2 |
Follow Orpha Labs: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14 ORL-1G - D-galactose - Glycogen Storage Disease, Type 14 | Phase 1 / Phase 2 | Unknown | Orpha Labs | 5 | 2017-10-31 | 2019-01-25 |
| Study of ORL-1M (D-mannose) in Patients With CDG-Ib ORL-1M - D-mannose - CDG Ib | Phase 1 / Phase 2 | Unknown | Orpha Labs | 5 | 2015-03-31 | 2019-01-25 |
| Study of ORL-1B in Patients With Biotinidase Deficiency ORL-1B - Biotinidase Deficiency | Phase 1 / Phase 2 | Completed | Orpha Labs | 20 | 2013-08-31 | 2018-01-17 |
| Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II L-fucose - Leukocyte Adhesion Deficiency, Type II | Phase 1 / Phase 2 | Completed | Orpha Labs | 4 | 2012-01-01 | 2019-01-25 |
Biotinidase Deficiency (1) · Congenital disorder of glycosylation type 1B (1) · Congenital disorder of glycosylation, type 2C (1) · Glycogen Storage Disease (1) · Glycogen Storage Disease XIV (1)
Fucose (1)
Turkey (Türkiye) (2)